• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TACTRA; PROSTHESIS PENILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TACTRA; PROSTHESIS PENILE Back to Search Results
Model Number 720081-01
Medical Device Problem Code Inadequacy of Device Shape and/or Size (1583)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/11/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient with this tactra malleable penile prosthesis was dissatisfied with the device, stating that it felt too short.A surgical procedure was performed in which the device was removed and replaced.There were no patient complications reported.
 
Event or Problem Description
It was reported that the patient with this tactra malleable penile prosthesis was dissatisfied with the device, stating that it felt too short.A surgical procedure was performed in which the device was removed and replaced.There were no patient complications reported.
 
Additional Manufacturer Narrative
Correction to b1: adverse event/product problem.Upon receipt at our quality assurance laboratory, this tactra malleable penile prosthesis underwent a thorough analysis.Microscopic inspection revealed that the cylinders were cut to 23 cm with a sharp instrument.The device history record (dhr) review confirmed that the device met all material, assembly and performance specifications.A review of the device instructions for use (ifu) was completed and did not reveal any evidence of device misuse, off label use, or failure to follow instructions.A risk review was completed and confirmed that the event of "length too short" was defined in the product risk documentation.This event type has been accounted for during analysis to support acceptable risk benefit for the product.Based on the information available, the conclusion code of known inherent risk of device was assigned to this investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTRA
Common Device Name
PROSTHESIS PENILE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key23839088
Report Number2124215-2025-91712
Device Sequence Number21290798
Product Code FAE
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
K183619
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2025
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/27/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model Number720081-01
Device Catalogue Number720081-01
Device Lot Number0040173899
Date Returned to Manufacturer12/05/2025
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/24/2025
Supplement Date Received by Manufacturer01/23/2026
Initial Report FDA Received Date12/18/2025
Supplement Report FDA Received Date05/27/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/22/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age68 YR
Patient SexMale
-
-